BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 and BRCA2 suggests that they are involved in two fundamental cellular processes: DNA damage repair and transcriptional regulation. We evaluate current knowledge of BRCA1 and BRCA2 functions to explain why mutations in BRCA1 and BRCA2 lead specifically to breast and ovarian cancer. The BRCA1 and BRCA2 genes contain unusually high densities of repetitive elements. These features of the BRCAs genomic regions contribute to chromosomal instability of these genes. We propose that somatic alterations of BRCA1 and BRCA2 are common and driven by rearrangements between repetitive elements. Inherited and somatic mutations occur in BRCA1 and BRCA2; virtually all somatic mutations are the result of large genomic rearrangements. What are the consequences of such large somatic mutations of BRCA1 and BRCA2 in women with or without inherited mutations? The breast and ovary are estrogen-responsive tissues. Beginning in puberty, the breast epithelium proliferates rapidly in response to fluctuating levels of estrogen. We present a genetic model outlining how BRCA-deficient cells may gain uncontrolled proliferation leading to tumor formation. Central to this model of BRCA-mediated tumorigenesis are estrogen-mediated proliferation of breast and ovarian epithelium and the distinctive genomic context of the BRCA genes.

[1]  T. Tsuruo,et al.  The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature. , 2000, Biochemical and biophysical research communications.

[2]  Thomas Ried,et al.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation , 1999, Nature Genetics.

[3]  R. Young,et al.  BRCA1 is a component of the RNA polymerase II holoenzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Alexander Kinev,et al.  BRCA1 Is Associated with a Human SWI/SNF-Related Complex Linking Chromatin Remodeling to Breast Cancer , 2000, Cell.

[5]  K. Pienta,et al.  Nuclear structure and the three‐dimensional organization of DNA , 1991, Journal of cellular biochemistry.

[6]  S. Elledge,et al.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. , 2000, Genes & development.

[7]  Hongtao Zhang,et al.  BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells , 1998, Oncogene.

[8]  D. Easton,et al.  Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome , 1992, Nature Genetics.

[9]  Y. Shiloh,et al.  Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response , 2000, Nature.

[10]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[11]  M. Erdos,et al.  BRCA1 inhibition of estrogen receptor signaling in transfected cells. , 1999, Science.

[12]  A. Bowcock,et al.  The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression* , 1998, The Journal of Biological Chemistry.

[13]  P. Devilee,et al.  Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. , 1995, British Journal of Cancer.

[14]  Mutsuko Ouchi,et al.  Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Jackson,et al.  Sequences attaching loops of nuclear and mitochondrial DNA to underlying structures in human cells: the role of transcription units. , 1996, Nucleic acids research.

[16]  S. Gasser,et al.  DNA loops: structural and functional properties of scaffold‐attached regions , 1992, Molecular microbiology.

[17]  M. Macleod,et al.  Regulation of BRCA1 Expression by the Rb-E2F Pathway* , 2000, The Journal of Biological Chemistry.

[18]  F. Couch,et al.  Induction of the BRCA2 Promoter by Nuclear Factor-κB* , 2000, The Journal of Biological Chemistry.

[19]  T. Kouzarides,et al.  BRCA2 associates with acetyltransferase activity when bound to P/CAF , 1998, Oncogene.

[20]  B. Weber,et al.  The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells , 1999, Oncogene.

[21]  Sean V Tavtigian,et al.  Characterization of a carboxy-terminal BRCA1 interacting protein , 1998, Oncogene.

[22]  R. White,et al.  BRCA1 is associated with the centrosome during mitosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Wen-Hwa Lee,et al.  Identification of a Novel Cytoplasmic Protein That Specifically Binds to Nuclear Localization Signal Motifs* , 1998, The Journal of Biological Chemistry.

[24]  M. Erdos,et al.  Role of direct interaction in BRCA1 inhibition of estrogen receptor activity , 2001, Oncogene.

[25]  A. Vincent-Salomon,et al.  Low expression of bcl-2 in Brca1-associated breast cancers , 2000, British Journal of Cancer.

[26]  Mary C. Rykowski,et al.  Human genome organization: Alu, LINES, and the molecular structure of metaphase chromosome bands , 1988, Cell.

[27]  M. Stratton,et al.  Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. , 1997, British Journal of Cancer.

[28]  C. Osborne,et al.  Binding of CtIP to the BRCT Repeats of BRCA1 Involved in the Transcription Regulation of p21 Is Disrupted Upon DNA Damage* , 1999, The Journal of Biological Chemistry.

[29]  H. Eggert,et al.  The elusive nuclear matrix. , 1992, European journal of biochemistry.

[30]  D. Easton,et al.  Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. , 1995, Oncogene.

[31]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[32]  A. Monteiro,et al.  BRCA1: exploring the links to transcription. , 2000, Trends in biochemical sciences.

[33]  H. Olsson.  Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[34]  D. Bentley,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1995, Nature.

[35]  M. King,et al.  Insights into the functions of BRCA1 and BRCA2. , 2000, Trends in genetics : TIG.

[36]  R. White,et al.  TGF-beta1 inhibits BRCA1 expression through a pathway that requires pRb. , 2000, Biochemical and biophysical research communications.

[37]  Yumay Chen,et al.  The Nuclear Localization Sequences of the BRCA1 Protein Interact with the Importin-α Subunit of the Nuclear Transport Signal Receptor* , 1996, The Journal of Biological Chemistry.

[38]  Heinz Ruffner,et al.  BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site , 1999, Molecular and Cellular Biology.

[39]  R. Fishel,et al.  BRCA1 and cell signaling , 2000, Oncogene.

[40]  I. Bièche,et al.  Overexpression of BRCA2 gene in sporadic breast tumours , 1999, Oncogene.

[41]  Yonghong Xiao,et al.  Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells , 1997, Cell.

[42]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[43]  H. Ruffner,et al.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Sam W. Lee,et al.  Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression , 2000, Molecular and Cellular Biology.

[45]  J. Parvin,et al.  BRCA1 interaction with RNA polymerase II reveals a role for hRPB2 and hRPB10α in activated transcription , 2000 .

[46]  C. Wang,et al.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. , 1999, Science.

[47]  Y. Houvras,et al.  BRCA1 Physically and Functionally Interacts with ATF1* , 2000, The Journal of Biological Chemistry.

[48]  P. J. Welch,et al.  Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Shao,et al.  The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter , 1999, Oncogene.

[50]  I. Irminger-Finger,et al.  The Functions of Breast Cancer Susceptibility Gene 1 (BRCA1) Product and Its Associated Proteins , 1999, Biological chemistry.

[51]  Anne M. Bowcock,et al.  Identification of a RING protein that can interact in vivo with the BRCA1 gene product , 1996, Nature Genetics.

[52]  P. L. Chen,et al.  Sequence-specific transcriptional corepressor function for BRCA1 through a novel zinc finger protein, ZBRK1. , 2000, Molecular cell.

[53]  Jong-Soo Lee,et al.  hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.

[54]  J. Parvin,et al.  BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A , 1998, Nature Genetics.

[55]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[56]  P. Pharoah,et al.  Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers , 2000, International journal of cancer.

[57]  D. Kioussis,et al.  Unexpected relationships between four large deletions in the human β-globin gene cluster , 1983, Cell.

[58]  H. Mefford,et al.  BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. , 1997, American journal of human genetics.

[59]  Hongtao Zhang,et al.  VCP, a weak ATPase involved in multiple cellular events, interacts physically with BRCA1 in the nucleus of living cells. , 2000, DNA and cell biology.

[60]  T. Kouzarides,et al.  The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase , 2000, Oncogene.

[61]  Keith D Wilkinson,et al.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression , 1998, Oncogene.

[62]  Debajit K. Biswas,et al.  Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells , 2000 .

[63]  Ralph Scully,et al.  Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage , 1997, Cell.

[64]  C. Deng,et al.  Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation , 2000, Oncogene.

[65]  S. Yeh,et al.  Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Smith,et al.  An entire functional mammary gland may comprise the progeny from a single cell. , 1998, Development.

[67]  B. Weber,et al.  Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. , 2000, American journal of human genetics.

[68]  C. Deng,et al.  Roles of BRCA1 and its interacting proteins , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[69]  Hui Tian,et al.  BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.

[70]  J M Trent,et al.  MYB oncogene amplification in hereditary BRCA1 breast cancer. , 2000, Cancer research.

[71]  M. Skolnick,et al.  BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.

[72]  E. Atlas,et al.  GA-binding protein α/β is a critical regulator of the BRCA1 promoter , 2000, Oncogene.

[73]  M. King,et al.  Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.

[74]  R. Scully,et al.  DNA polymerase stalling, sister chromatid recombination and the BRCA genes , 2000, Oncogene.

[75]  R. Shiekhattar,et al.  A Human BRCA2 Complex Containing a Structural DNA Binding Component Influences Cell Cycle Progression , 2001, Cell.

[76]  Wen-Hwa Lee,et al.  Lessons learned from BRCA1 and BRCA2 , 2000, Oncogene.

[77]  F. Christians,et al.  Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1 , 1999, Cell.

[78]  T. Katagiri,et al.  Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1. , 2000, Cancer research.

[79]  T. Ouchi,et al.  BRCA1 regulates p53-dependent gene expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[80]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[81]  B. Karlan,et al.  Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas , 1999, Nature Genetics.

[82]  Huichen Wang,et al.  BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases , 1997, Oncogene.

[83]  V. Yamazaki,et al.  A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage , 2000, Current Biology.

[84]  R. L. Baldwin,et al.  BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. , 2000, Cancer research.

[85]  A. Wallgren,et al.  A large deletion disrupts the exon 3 transcription activation domain of the BRCA2 gene in a breast/ovarian cancer family. , 1998, Cancer research.

[86]  A. Ashworth,et al.  Interaction between the Product of the Breast Cancer Susceptibility Gene BRCA2 and DSS1, a Protein Functionally Conserved from Yeast to Mammals , 1999, Molecular and Cellular Biology.

[87]  E. Liu,et al.  BRCA1-associated growth arrest is RB-dependent. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[88]  R. Yarden,et al.  BRCA1 interacts with components of the histone deacetylase complex. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[89]  L. Hood,et al.  Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. , 1996, Genome research.